By breaking down traditional organizational silos to bring together the chief medical officer and the chief marketing officer, companies can unite the forces of clinical best practices with direct-to-consumer response marketing.
CVS excludes 31 drugs including Viagra from its 2016 formulary; Sanofi partners with Evotec on stem-cell treatment development; primary-care physicians may hesitate to prescribe Truvada for PrEP
AstraZeneca signs two immuno-oncology collaboration deals; UK cost watchdog goes after Pfizer over epilepsy medication price tag; Boston Globe reports drugmakers are funneling more money through CME programs
Drugs that turn cancer into a chronic disease need new marketing strategies: report
Findings of a new report suggest ways pharma should rethink its commercial and R&D decisions in light of improved survival rates associated with some cancers.
Astellas to use rugby to promote prostate-cancer awareness
August 5, 2015
6:30 pm
The drugmaker, which sells prostate-cancer treatment Xtandi, wants social-media users to help spread the word about the disease
Five things for pharma marketers to know: Wednesday, August 5
The FDA updates Gilenya’s label over definite case of PML; generic drug companies are consolidating for negotiating power; the FDA revises guidance on DTC risk information